SCHEMBL4371675

SCHEMBL4371675

COC(=O)C(Cc1cccs1)C(=O)O

nearest known ligand 0.72

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.72
RAB9A P51151 3/20 0.50
CTSC P53634 1/20 0.49
LMNA P02545 1/20 0.48
ALDH1A1 P00352 1/20 0.48
SLC1A3 P43003 1/20 0.47
SLC1A2 P43004 1/20 0.47
SLC1A1 P43005 1/20 0.47
NPC1 O15118 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9727077 0.93 CYP2C19 (0.66) CYP2C19RAB9ACTSCLMNAALDH1A1
SCHEMBL934056 0.86 CYP2C19 (0.70) CYP2C19RAB9ACTSCLMNAALDH1A1
SCHEMBL1766985 0.84 CYP2C19 (1.00) CYP2C19RAB9ACTSCLMNAALDH1A1
SCHEMBL28997199 0.84 CYP2C19 (0.72) CYP2C19RAB9ACTSCLMNAALDH1A1
SCHEMBL8413466 0.82 RAB9A (0.55) CYP2C19RAB9ACTSCLMNAALDH1A1
SCHEMBL19699149 0.81 CTSC (0.59) CYP2C19RAB9ACTSCSLC1A3SLC1A2
SCHEMBL2058609 0.81 CTSC (0.59) CYP2C19RAB9ACTSCSLC1A3SLC1A2
SCHEMBL1631750 0.81 CTSC (0.59) CYP2C19RAB9ACTSCSLC1A3SLC1A2
Hydrochloric Acid SCHEMBL28362983 0.79 CTSC (0.58) CYP2C19RAB9ACTSCSLC1A3SLC1A2
Hydrochloric Acid SCHEMBL7066923 0.79 CTSC (0.58) CYP2C19RAB9ACTSCSLC1A3SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009084028-A2 IMPROVED PROCESS FOR MANUFACTURING ANHYDROUS (E)-3-[2-BUTYL-1- {(4-CARBOXYPHENYL) METHYL}-1H-IMIDAZOLE-5-YL]-(THIOPHEN-2- YLMETHYL)PROP-2-ENOIC ACID METHANE SULFONATE NEULAND LABORATORIES LTD (IN) 2009-07-09 WO claimed
WO-2009084028-A2 IMPROVED PROCESS FOR MANUFACTURING ANHYDROUS (E)-3-[2-BUTYL-1- {(4-CARBOXYPHENYL) METHYL}-1H-IMIDAZOLE-5-YL]-(THIOPHEN-2- YLMETHYL)PROP-2-ENOIC ACID METHANE SULFONATE NEULAND LABORATORIES LTD (IN) 2009-07-09 WO disclosed
US-5169841-A Enzyme inhibitors, hypotensive agents, high enteral bioauailability HOECHST AKTIENGESELLSCHAFT (DE) 1992-12-08 US disclosed